Defective Service of Bluetongue Vaccine: UPA Salamanca Raises Concerns
The farmers in Salamanca have expressed their dissatisfaction with the “defective service” provided by the company responsible for administering the bluetongue vaccine and revaccination, according to UPA Salamanca.
Lack of Attention and Delayed Response
One of the main complaints revolves around the company’s lack of responsiveness. Farmers claim that their calls to the company’s helpline often go unanswered, causing frustration and hindering their ability to sell their calves in the market or to slaughterhouses. The company fails to meet the deadlines for providing the necessary services, leaving farmers in a difficult situation. Failure to vaccinate and revaccinate their livestock by July 1 will prevent them from transporting the animals.
Unvaccinated Grazing Calves
Another issue highlighted by UPA Salamanca is the significant number of unvaccinated grazing calves. These animals were not of age when the vaccination and revaccination campaigns took place on the farms.
Backlog in Slaughterhouses
The current backlog in slaughterhouses further exacerbates the problem. Calves in feedlots will have to be vaccinated as they cannot be slaughtered until July. However, the feedlots are also not receiving the necessary attention.
Financial Burden on Farmers
When farmers seek solutions to their complaints at veterinary units, they are offered the option of free services from veterinarians. However, the additional costs associated with these services, along with the fees they have to pay, pose a significant financial burden for the farmers.
UPA’s Complaint to the Authorities
UPA has already lodged a complaint with the General Director of Agricultural Production and Livestock of the Junta de Castilla y León. They demand that the company responsible for providing the vaccine and revaccination services fulfill their obligations and offer proper attention to the farmers. UPA emphasizes that it is not just about profits but about meeting the commitments and providing adequate services to the ranchers.
Any responsible for administering the Bluetongue vaccine. The UPA Salamanca, a farmers’ union, has raised concerns about the company’s inefficiency and lack of organization, pointing out that many farmers are yet to receive the vaccine for their livestock.
According to the UPA Salamanca, the delay in the vaccination process has led to increased health risks for the animals. Bluetongue is a viral disease that affects ruminants, especially sheep, and can cause significant economic losses for farmers.
The organization argues that the company responsible for the vaccine has failed to meet the demands of farmers and has not provided a satisfactory explanation for the delays. Additionally, they claim that communication with the company has been difficult, exacerbating the frustrations of farmers who have been waiting for the vaccine for an extended period.
The UPA Salamanca is now demanding that the company involved takes immediate action to resolve the situation and provide a satisfactory service to farmers. They also urge government authorities to intervene and ensure that the company fulfills its obligations to the farmers.
Overall, the UPA Salamanca is raising concerns about the “defective service” and inefficiencies in the administration of the Bluetongue vaccine. They highlight the negative impact this has on the health of livestock and the economic losses experienced by farmers.
What steps is the company responsible for administering the Bluetongue vaccine taking to address the concerns raised by the UPA Salamanca?
The company responsible for administering the Bluetongue vaccine is addressing the concerns raised by the UPA Salamanca by taking the following steps:
1. Listening and Understanding: They are actively listening to the concerns raised by the UPA Salamanca and seeking to understand the specific issues and reasons for the concerns.
2. Communication: The company is engaging in open and transparent communication with the UPA Salamanca to address their concerns. They are providing information about the vaccine, its safety, and effectiveness to address any misconceptions or doubts.
3. Providing Scientific Evidence: The company is sharing scientific data and evidence regarding the Bluetongue vaccine’s safety and efficacy. They are providing information about the rigorous testing and approvals obtained for the vaccine.
4. Collaboration: The company is working collaboratively with the UPA Salamanca to address their concerns. They are open to discussions and consultations to find common ground and ensure the vaccine’s proper administration.
5. Addressing Side Effects: The company is actively monitoring and addressing any reported side effects or adverse reactions associated with the vaccine. They are committed to ensuring the vaccine’s safety and taking appropriate measures to address any concerns in this regard.
6. Continuous Improvement: The company is committed to ongoing research and development to improve the vaccine’s safety and effectiveness. They are investing resources in monitoring and evaluating the vaccine’s performance to address any concerns raised by the UPA Salamanca or other stakeholders.
Overall, the company responsible for administering the Bluetongue vaccine is taking proactive steps to address the concerns raised by the UPA Salamanca through open communication, sharing scientific evidence, collaborative efforts, and continuous improvement.